Search Within

Howard Scher

Formats
  1. Journal Article (626)
  2. Meeting Abstract (463)
  3. Book Section (13)
  4. Conference Paper (11)
  5. Editorial (7)
  6. Review (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Research Letter (2)
Groups
  1. Department of Medicine (1133)
  2. Genitourinary Oncology Service (1133)
  3. Solid Tumor Oncology Division (1133)
  4. GSK Faculty (305)
  5. Sloan Kettering Institute Faculty (249)
  6. Department of Pathology and Laboratory Medicine (241)

More Groups

People
  1. Michael Morris (217)
  2. Susan Slovin (140)
  3. Dana Rathkopf (133)
  4. Daniel Danila (112)
  5. Steven Larson (110)
  6. Victor Reuter (97)

More People

Years
  1. 2025 (11)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (25)
  5. 2021 (19)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (328)
  2. Clinical Cancer Research (85)
  3. Cancer Research (54)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (47)
  5. Journal of Urology (36)
  6. European Urology (35)

More Publications

Publishers
  1. American Society of Clinical Oncology (335)
  2. American Association for Cancer Research (197)
  3. Elsevier Science, Inc. (119)
  4. Elsevier Inc. (72)
  5. Nature Publishing Group (58)
  6. Oxford University Press (47)

More Publishers

Results (1133)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
    Journal Article

    Butler, L. M.; Webb, Y.; Agus, D. B.; Higgins, B.; Tolentino, T. R.; Kutko, M. C.; LaQuaglia, M. P.; Drobnjak, M.; Cordon-Cardo, C.; Scher, H. I.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • The collection of indirect and nonmedical direct costs (COIN) form: A new tool for collecting the invisible costs of androgen independent prostate carcinoma
    Journal Article

    Sherman, E. J.; Pfister, D. G.; Ruchlin, H. S.; Rubin, D. M.; Radzyner, M. H.; Kelleher, G. H.; Slovin, S. F.; Kelly, W. K.; Scher, H. I.
    Cancer (2001)

    Fulltext@MSK | Save
  • Tn-cluster (c) -KLH/PAM vaccine conjugates in biochemically relapsed prostate cancer (PC): Phase I trial results
    Meeting Abstract

    Slovin, S. F.; Ragupathi, G.; Olkiewicz, K.; Tilak, J.; Terry, K.; Moore, K.; Fazzari, M.; Jakubowiak, J.; Lu, L.; Livingston, P. O.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • HER-2/NEU membrane overexpression in prostate cancer (PC)
    Meeting Abstract

    Osman, I. A.; Scher, H.; Drobnjak, M.; Morris, M.; Fazzari, M.; Cordon-Cardo, C.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Potentiation of cytotoxic agents against human tumors in mice by ZD1839 (IressaTM), an inhibitor of EGFR tyrosine kinase, does not require high levels of expression of EGFR
    Meeting Abstract

    Sirotnak, F. M.; Zakowski, M. F.; Miller, V. A.; Scher, H. I.; Kris, M. G.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Antibody to VEGF slows growth of an androgen-independent xenograft model of prostate cancer
    Meeting Abstract

    Higgins, B.; Fox, W. D.; Scher, H. I.; Maiese, K. M.; Drobnjak, M.; Cordon-Cardo, C.; Agus, D. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Anti-tumor activity of Apo2 ligand (TRAIL) in androgen-dependent and androgen-independent human prostate cancer xenograft models
    Meeting Abstract

    Maiese, K. M.; Scher, H. I.; Fox, W. D.; Higgins, B.; Drobnjak, M.; Cordon-Cardo, C.; Agus, D. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Hybrid polar inhibitors of histone deacetylase suppress the growth of the CWR22 human prostate cancer xenograft
    Meeting Abstract

    Butler, L. M.; Higgins, B.; Fox, W. D.; Agus, D. B.; Cordon-Cardo, C.; Scher, H. I.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Molecular characterization of circulating prostatic tumor cells after leukapheresis in prostatic carcinoma patients
    Meeting Abstract

    Bhattacharya, S.; Scher, H.; Osman, I.; Juan, G.; Hutchinson, B.; Cordon-Cardo, C.; Ghossein, R. A.
    Journal of Histochemistry and Cytochemistry (2000)

    Fulltext@MSK | Save
  • 17-allyl-amino-seldanamycin induces HER2 degradation and AKT inactivation in a human breast cancer xenograft model
    Meeting Abstract

    Solit, D.; Munster, P.; Basso, A.; Tong, W.; Agus, D.; Scher, H.; Norton, L.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save